Is Barinthus Biotherapeutics plc (BRNS) a Buy, Sell, or Hold?
Barinthus Biotherapeutics plc
NASDAQ:BRNS
$0.6122 USD
$0.0 (0.36%)
- Volume
- 26.66K
- Average Volume
- 69.38K
- Market Capitalization
- $25.01M
- P/E Ratio
- -0.47
- Dividend Yield
- 0.00%
- Price Target
- $3.00
- Year High
- $2.92
- Year Low
- $0.51
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $6.05
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
10
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
0
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ -
BRNS Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
BRNS Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Swirsky Douglas J | officer | 2026-05-01 | 0 | 2026-05-01 | |
| Hammacher Alex | director | 2025-06-10 | A-Award | 1 | 2025-06-11 |
| Wright Robin | director | 2025-06-10 | A-Award | 1 | 2025-06-11 |
| Morgon Pierre A. | director | 2025-06-10 | A-Award | 1 | 2025-06-11 |
| Phillips Anne M. | director | 2025-06-10 | A-Award | 1 | 2025-06-11 |
| Scheeren Joseph | director | 2025-06-10 | A-Award | 1 | 2025-06-11 |
| DAWES KAREN A | director | 2025-06-10 | A-Award | 1 | 2025-06-11 |
| Brown Gemma | officer: Chief Financial Officer | 2025-02-03 | A-Award | 1 | 2025-02-05 |
| Enright William | director, officer: Chief Executive Officer | 2025-02-03 | A-Award | 1 | 2025-02-05 |
| Griffiths Graham | officer: Chief Business Officer | 2025-02-03 | A-Award | 1 | 2025-02-05 |
| Hooftman Leon | officer: Chief Medical Officer | 2025-02-03 | A-Award | 1 | 2025-02-05 |
| Lynn Geoffrey | officer: Chief Scientific Officer | 2024-12-17 | 0 | 2024-12-31 | |
| Lynn Geoffrey | officer: Chief Scientific Officer | 2024-12-17 | 0 | 2024-12-20 | |
| Lynn Geoffrey | officer: Chief Scientific Officer | 2024-12-17 | 0 | 2024-12-20 | |
| Lynn Geoffrey | officer: Chief Scientific Officer | 2024-12-17 | 11.12 | 2024-12-20 | |
| Lynn Geoffrey | officer: Chief Scientific Officer | 2024-12-17 | 0.98 | 2024-12-20 | |
| Lynn Geoffrey | officer: Chief Scientific Officer | 2024-12-17 | 2.4 | 2024-12-20 | |
| Lynn Geoffrey | officer: Chief Scientific Officer | 2024-12-17 | 3.7 | 2024-12-20 | |
| Hooftman Leon | officer: Chief Medical Officer | 2024-06-03 | A-Award | 2 | 2024-06-18 |
| Hooftman Leon | officer | 2024-06-03 | 0 | 2024-06-18 | |
| DAWES KAREN A | director | 2024-05-10 | A-Award | 2.34 | 2024-05-14 |
| Scheeren Joseph | director | 2024-05-10 | A-Award | 2.34 | 2024-05-14 |
| Phillips Anne M. | director | 2024-05-10 | A-Award | 2.34 | 2024-05-14 |
| Hammacher Alex | director | 2024-05-10 | A-Award | 2.34 | 2024-05-14 |
| Morgon Pierre A. | director | 2024-05-10 | A-Award | 2.34 | 2024-05-14 |
| Wright Robin | director | 2024-05-10 | A-Award | 2.34 | 2024-05-14 |